Skip To Content

Staff & Students

Postdoctoral Fellows

 

 

V. Bachmann

 

Dr. Verena Bachmann

Position: Postdoctoral Fellow

E-mail: vbachman@ualberta.ca

Phone: (780) 492-4437

Supervisor: Dr. Stefan Pukatzki

 

 

Academic Interests:

I am combining bacterial genetics and fluoresecence microscopy to identify novel virulence factors of Vibrio cholerae.

 

R. BhatDr. Rakesh Bhat

Position: Postdoctoral Fellow

E-mail: bhat@ualberta.ca

Phone: (780) 492-1216

Supervisor: Dr. Michael Houghton


 


Academic Interests:

Cryptogenic chronic hepatitis is a subgroup thought to have viral and autoimmune condition presented with varying degrees of hepatocellular necrosis and inflammation. In Dr. Houghton’s lab I will be working to elucidate the role of viral pathogenesis in cryptogenic chronic hepatitis. I will be using systems biology approach to discover new pathogens and target molecules in different human infectious diseases VIZ Cryptogenic chronic hepatitis, MS, IBD.

Non-Academic:

In my spare time I enjoy traveling and exploring new places, mountain climbing, photography, driving and fixing computer software and hardware problems.

Awards:

  • “Distinguished talk” at School of Internal Medicine Research Day, University of Alberta, Edmonton, 2011
  • endMS (MS Society of Canada), Travel award, Whistler, CAN 2010
  • European Science Foundation for Functional Genomics, Travel award, Bologna, IT 2004

Publications:

  1. Andre Deslauriers, Amir Afkhami-Goli, Amber Paul, Rakesh K. Bhat, Shaona Acharjee, Kristofor Ellestad, Farshid Noorbakhsh, Marek Michalak and Christopher Power, “Neuroinflammation and endoplasmic reticulum stress co-regulation mediate demyelination and neurodegeneration”, (Acepted -Journal of Immunology)

  2. Rakesh K. Bhat, Kristofor K Ellestad, Matt B Wheatley and Christopher Power, “Brain Syncytin-1 is encoded by a single chromosomal locus in multiple sclerosis”, PLoS ONE 2011; 6(4)

  3. Christopher Power, Joseph M. Antony, Kristofer K. Ellestad, Andre M. Deslauriers, Rakesh Bhat, Farshid Noorbakhsh, “The human Microbiome in multiple sclerosis: pathogenic or protective constituents?” Can J Neurol Sci 2010; 37

  4. Joseph M. Antony, Andre M. Deslauriers, Rakesh K. Bhat, Kristofer K. Ellestad, Christopher Power, “Human endogenous retroviruses and multiple sclerosis: Innocent bystanders or disease determinants?” Biochim Biophys Acta-Mol Bio Dis, 2010

  5. William C. Florence, Rakesh K. Bhat and Sebastian Joyce, “CD1d-Restricted Glycolipid Antigens: Presentation Principles, Recognition Logic and Functional Consequences”, Expert Reviews in Molecular Medicine, 2008, 10, 1-27.

  6. Rakesh K. Bhat and Stefan Berger, “The 5S Subunit of Transcarboxylase Interacts with Free Biotin as Studied by Transferred-NOESY and Saturation Transfer Difference NMR”, Protein and Peptide Letters, 2008, 15(6), 624-629.

  7. Rakesh K. Bhat and Stefan Berger, “New and easy strategy for cloning, expression, purification, and characterization of the 5S subunit of transcarboxylase from Propionibacterium f. shermanii”, Prep Biochem Biotechnol, 2007, 37(1), 13-26.

  8. Claudia Peikert, Karsten Seeger, Rakesh K. Bhat and Stefan Berger, “Determination of the binding specificity of the 12S subunit of the transcarboxylase by saturation transfer difference NMR”, Org Biomol Chem, 2004, 2, 1777-1781

 

B. Dauber
Dr. Bianca Dauber

Position: Postdoctoral Fellow

E-mail: dauber@ualberta.ca

Phone: (780) 492-2317

Supervisor: Dr. Jim Smiley

Alma Mater: Philipps University Marburg, Germany

 


Academic Interests:

I am studying the role of the HSV-1 virion host shutoff (vhs) protein in boosting translation of viral late gene products

Non-Academic Interests:

Traveling, gardening, aikido and biking.

Awards:

Alberta Innovates Health Solutions Post-Doctoral Fellowship

Publications:

1) Ma W, Brenner D, Wang Z, Dauber B, Ehrhardt C, Högner K, Herold S, Ludwig S, Wolff T, Yu K, Richt JA, Planz O, Pleschka S. (2010) The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol. 2010 Feb;84(4):2122-33.

2) Dauber B, Martínez-Sobrido L, Schneider J, Hai R, Waibler Z, Kalinke U, García-Sastre A, Wolff T. (2009) Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog. 2009 Jun;5(6):e1000473.

3) Schneider J, Dauber B, Melén K, Julkunen I, Wolff T. (2009) Analysis of influenza B Virus NS1 protein trafficking reveals a novel interaction with nuclear speckle domains. J Virol. 2009 Jan;83(2):701-11.

4) Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T. (2007) IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol. 2007 Apr;9(4):930-8.

5) Dauber B, Schneider J, Wolff T. (2006) Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol.  2006 Dec;80(23):11667-77.

6) Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J. (2005) The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18590-5.

7) Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, Krappmann D, Heins G., Erhardt C, Wolff T (2005) Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13640-5.

8) Donelan N R, Dauber B, Wang X, Basler C F, Wolff T, Garcia-Sastre, A (2004) The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol. 2004 Nov;78(21):11574-82.

9) Dauber B, Heins G, Wolff T. (2004) The influenza B Virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol. 2004 Feb;78(4):1865-72.


fillerperson

Dr. Heather Eaton

Position: Postdoctoral Fellow

E-mail: heeaton@ualberta.ca

Phone: (780) 492-2317

Supervisor: Dr. Jim Smiley

 

 

 

 

Amir LandiDr. Amir Landi

Position: Postdoctoral Fellow

E-mail: landi@ualberta.ca

Phone: (780) 492-2718/492-1216

Supervisor: Dr. Michael Houghton

Alma Mater: MD (Tehran University, School of Medicine, Tehran, Iran)
PhD (University of Saskatchewan, Saskatoon, Canada)

 

Academic Interests:

In my research, different vaccine candidates for hepatitis C virus will be evaluated for inducing proper immune response inin vivo models.

Awards:

  • Devolved Departmental Scholarship, Veterinary Microbiology, University of Saskatchewan (2005-2008)
  • Merial Scholarship for outstanding achievement (September 2007)
  • Travel Awards, University of Saskatchewan.
      • Cecil E. Doige Fund (September 2006)
      • Graduate Studies and Research (September 2006)
      • Graduate Studies and Research (September 2009)
  • Top Poster Award, Annual Western College of Veterinary medicine (WCVM) Graduate Student Poster Day, University of Saskatchewan (March 2006)

Publications:

1) Landi A, Babiuk LA, and van Drunen Littel-van den Hurk S.
"Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-a or LPS" Immunobiology. 2010. November 25. [Epub ahead of print] PMID: 21183242

2) Landi A, Yu H, Babiuk, LA and van Drunen Littel-van den Hurk S. "Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation". Journal of Viral Hepatitis. 2010. August 3. [Epub ahead of print] PMID: 20701679.

3) Kovacs-Nolan J, Latimer L, Landi A, Jenssen H, Hancock REW, Babiuk LA and van Drunen Littel-van den Hurk S. "The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent humoral and cellular immune responses in mice". Vaccine, 27 (2009) 2055-2064.

4) Liang R, vanden Hurk JV, Landi A, Lawman Z, Townsend D, Babiuk LA and van Drunen Littel-van den Hurk S. "DNA prime - Protein Boost Strategies Protect Cattle from BVDV Type 2 Challenge" Journal of General Virology, February 2008, 89, 453-466.

5) Landi A, Babiuk LA, van Drunen Littel-van den Hurk S. "High transfection efficiency, gene expression and viability of monocyte-derived human dendritic cells after non-viral gene transfer" Journal of Leukocyte Biology, October 2007, 82, 849-860.

6) Khosravi AD, Torabizadeh R, Landi A. "Investigation of the Level of IgG, IgM and IgA Antibodies against A60 Antigen in Turberculosis Patients Referred to PHLS, Ahvaz, Iran". Pakistan Journal of Medical Sciences, October - December 2005, 21 (4), 865-869.

 

A. Levin

 

Dr. Aviad Levin

Position: Postdoctoral Fellow

E-mail: aviad@ualberta.ca

Phone: (780) 492-9819

Supervisor: Dr. Lorne Tyrrell &
Dr. Richard Wozniak

 

 

Academic Interests:

My research deals with the involvement of nuclear import pathway proteins in Hepatitis C virus infection. This research involve proteins interaction, virus host interactions, peptides, virology, nuclear transport.

Non-academic Interests:

Cooking, photography, writing, hiking, traveling and reading.

Awards:

  • Dr. Bert L. Schram Award for the best poster presentation presented by the European Peptide Society and the ESCOM Science Foundation (2008).
  • Prof. Noah Lichtenstein Award for excellence students (2008)

Publications:

1) Levin A., Benyamini H., Hayouka Z., Friedler A. and Loyter A. Peptides that bind the HIV-1 integrase and modulate its enzymatic activity: Kinetic studies and mode of action. FEBS Journal. 278(2): 316-330, 2011.

2) Hayouka Z., Levin A., Loyter A. and Friedler A. Peptide inhibitors of the HIV-1 integrase protein. (Review) Chemistry in Israel - Bulletin of the Israel Chemical Society 25: 20-28, 2010 available at http://www.chemistry.org.il/Files/426_ICS_25-final.pdf.

3) Hayouka Z., Hurevich M., Levin A., Benyamini H., Iosub A., Maes M., Shalev DE., Loyter A., Gilon C. and Friedler A. Mimicking protein active sites by cyclic peptides selected from conformational libraries. Bioorganic & Medicinal Chemistry. 18(23): 8388-8395, 2010.

4) Levin A., Loyter A., and Bukrinsky M. Strategies to inhibit viral protein nuclear import: HIV-1 as a target. (Review) In press BBA – Molecular Cell Research. doi: 10.1016/j.bbamcr.2010.07.010.

5) Levin A., Hayouka Z., FriedlerA. and Loyter A. A Novel Approach to Eradicate HIV-1 From Infected Cultured Cells. AIDS Research and Therapy 7: 31, 2010.

6) Levin A., Hayouka Z., FriedlerA. and Loyter A. Peptides derived from the HIV-1 integrase promote HIV-1 infection and multi-integration of viral cDNA in LEDGF/p75-knockdown cells. Virology Journal 7(1): 177, 2010.

7) Levin A., Hayouka Z., Friedler A. and Loyter A. Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells. Nucleus 1(5): 422-431, 2010.

8) Levin A., Hayouka Z., Helfer M., Brack-Werner R., Friedler A. and Loyter A. Stimulation of the HIV-1 Integrase Enzymatic Activity and cDNA Integration by a Peptide Derived from the Integrase Protein. Biopolymers, 93(8): 740-751, 2010.

9) Levin A., Hayouka Z., Friedler A., Brack-Werner R., Volsky DJ. and Loyter A. A novel role for the viral Rev protein in promoting resistance to super-infection by Human Immunodeficiency Virus type 1. Journal of General Virology, 91: 1503-1513, 2010.

10) Levin A., Hayouka Z., FriedlerA. and Loyter A. Over expression of the HIV-1 Rev promote death in nondividing eukaryotic cells. Virus Genes, 40(3): 341-346, 2010.

11) Levin A., Hayouka Z., FriedlerA. and Loyter A. Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein. Nucleus 1(2): 190-201, 2010.

12) Hayouka Z., Levin A., Maes M., Hadas E., Shalev DE., Volsky DJ., Loyter A. and Friedler A. Mechanism of action of the HIV-1 Integrase Inhibitory Peptide LEDGF 361-370. Biochemical and Biophysical Research Communications, 394(2): 260-265, 2010.

13) Levin A., Armon-Omer A., RozenbluhJ., Melamed-Book N., Graessmann A., Waigmann E. and Loyter A. Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal. Retrovirology 6:112, 2009.

14) Levin A., Rosenbluh J., Hayouka Z., Friedler A. and Loyter A. Integration of the HIV-1 DNA is regulated by interplay between viral Rev and cellular LEDGF/p75 proteins. Molecular Medicine, 16(1-2):34-44, 2010.

15) Levin A., Hayouka Z., Brack-Werner R., Volsky DJ., Friedler A. and Loyter A. Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration. Protein Engineering Design and Selection, 22(12): 753-63, 2009.

16) Maes M., Levin A.,, Hayouka Z., Shalev DE., Loyter A. and Friedler A. Peptide inhibitors of HIV-1 integrase: From mechanistic studies to development of improved lead compounds. Bioorganic & Medicinal Chemistry, 17(22): 7635-42, 2009.

17) Levin A., Hayouka Z., Helfer M., Brack-Werner R., Friedler A. and Loyter A. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration. PLoS ONE, 4(1): e4155, 2009.

18) Levin A., Rubinstein-Guini M., Kuznetzova L. and Stram Y. Cleavage of Akabane virus S RNA in the brain of infected Ruminants. Virus Genes, 36(2): 375-81, 2008.

19) Hayouka Z., Rosenbluh J., Levin A., Maes M., Loyter A. and Friedler A. Peptides derived from HIV-1 Rev inhibit HIV-1 integrase in a shiftide mechanism. Biopolymers, 90 (4):481-7, 2008.

20) Armon-Omer A., Levin A., Hayouka Z., Butz K., Hoppe-Seyler F., Loya S., Hizi A., Friedler A. and Loyter A. Correlation between shiftide activity and integrase inhibition by peptide selected from a combinatorial library. Journal of Molecular Biology, 376(4): 971-82, 2008.

21) Rosenbluh J., Hayuoka Z., Loya S., Levin A., Armon-Omer A., Britan E., Hizi A., Kotler M., Friedler A. and Loyter A. Interaction between HIV-1 Rev and integrase proteins: A basis for the development of Anti-HIV peptides. Journal of Biological Chemistry, 282(21):15743-53, 2007.

22) Hayouka Z., Rosenbluh J., Levin A., Loya S., Lebendiker M., Veprintsev D., Kotler M., Hizi A., Loyter A. and Friedler A. Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proceedings of the National Academy of Sciences, 104(20):8316-21, 2007.

23) Levin A., Kutznetova L., Rubinstein-Guini M. and Stram Y. Highly effective siRNA genes able to completely inhibit Akabane virus replication. Virus Research, 120(1-2):121-7, 2006.

24) Stram Y., Kuznetzova L., Levin A., Yadin H. and Rubinstein-Giuni M. A real-time RT-quantative(q)PCR for the detection of bovine ephemeral fever virus. Journal of Virological Methods, 130(1-2):1-6, 2005.

 

 

fillerperson

Dr. Max Rosario

Position: Postdoctoral Fellow

E-mail: mrosario@ualberta.ca

Phone: (780) 492-1216

Supervisor: Dr. Michael Houghton

Alma Mater: Oxford University

 

 

Academic Interests:

I am interested in T-cell responses as related to chronic viral infections and vaccine development.

 

santer

Dr. Deanna Santer

Position: Postdoctoral Fellow

E-mail: deanna.santer@ualberta.ca

Phone: (780) 492-1216

Supervisor: Dr. Michael Houghton

Alma Mater: University of Washington (PhD)

 

Academic Interests:

My research will look into the mechanism of B cell lymphoproiferative disease associated with Hepatitis C virus infection.

Non-Academic Interests:

Most sports & travelling

Awards:

  • CIHR postdoctoral fellowship (2012-2015)
  • Alberta Innovates Health Solutions Postdoctoral Fellowship (2011-2014)
  • Exceptional Student Award (Cyto 2010 Conference)
  • Ray Owen Young Investigator Award (Midwinter Conference of Immunologists 2010)
  • NSERC PGS-D/M (2005-2009)

Publications:

1) Santer DM, Wiedeman AE, Teal TH, Ghosh P, Elkon KB. 2012. Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes. J Immunol. Jan 15;188(2):902-15.

2) Steffen I, Tyrrell DL, Stein E, Montalvo L, Lee TH, Zhou Y, Lu K, Switzer WM, Tang S, Jia H, Hockman D, Santer DM, Logan M, Landi A, Law J, Houghton M, Simmons G. 2011. No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome. PLoS One. 6(11):e27870.

3) Santer DM, Hall BE, George TC, Liu CL, Utz PJ, Arkwright PD, Elkon KB. 2010. C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. J Immunol. 185(8):4738-4749.

4) Chino T, Santer DM, Giordano D, Chen C, Li C, Chen C-H, Darveau RP, Clark EA. 2009. Effects of oral commensal and pathogenic bacteria on human monocyte derived dendritic cells. Oral Microbiol Immunol. Apr;24(2):96-103.

5) Santer DM, Yoshio T, Minota S, Möller T, Elkon KB. 2009. Potent Induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol. 182(2):1192-1201.

6) Kim D, Peck A, Santer D, Patole P, Schwartz SM, Molitor JA, Arnett FC, Elkon KB. 2008. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Arthritis Rheum. 58(7):2163-2173.

7) Schoenborn JR, Dorschner MO, Sekimata M, Santer DM, Shnyreva M, Fitzpatrick DR, Stamatoyannopoulos JA, Wilson CB. 2007. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat Immunol. 8(7):732-742.

 

B. Thomas

Dr. Brad Thomas

Position: Postdoctoral Fellow

E-mail: brad.thomas@ualberta.ca

Phone: (780) 492-9819

Supervisor: Dr. Lorne Tyrrell

Academic Interests: My vision of science is to understand how the immune system interacts with damaged tissue to promote regeneration. Where damage could be endogenous or pathogen induced. I'm curious to understand the mechanism of immune activation with respect to tissue remodelling. I want to better understand the processes of inflammation, proliferation, apoptosis, and cancer in the context of disease and tissue regeneration.

Awards

  • Fellowship, National CIHR Research Training Program in Hepatitis C (NCRTP) (2010)
  • Full time Studentship, Alberta Heritage Foundation for Medical Research (2006)
  • Doctoral Research Award, Canadian Institute of Health Research (CIHR) (2005)
  • William H. Davies Medical Research Scholarship (2003-04)
  • Stem Cell Network of Canada, Research Student Award(2001-04)

Non-academic Interests: Strong background in molecular biology, and developing recombination technologies. Enjoy reading about science. For fun I like to ski, run, mountain climb, kayak, and I dabble in photography, and graphic design.

Publications:

1) Adjuvant activity of a Bacteriophage Lambda subunit vaccine, B.Thomas, E. Long, S. Nishikawa, C. Chatten, S. Robbins, O. Bathe, F. Jirik, D. Rancourt (in prep)

2) In vitromodel of oncogenic transformation via cartilage differentiation of human induced pluripotent stem cells, A. Yamashita, B. Thomas, G.Meng G, A. Hotta A, J. Ellis J, D.Rancourt, (in prep)

3) Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophageλsubunit vaccine, B.S. Thomas, S. Nishikawa, K. Ito, P. Chopra, N. Sharma, D.H. Evans, D.L.J. Tyrrell, O. Bathe, D. Rancourt. (2012). Vaccine. 30(6):998-1008

4) A model for GFRα4 function and a potential modifying role in multiple endocrine neoplasia 2., J. Vanhorne, S. Andrew, K. Harrison, S. Taylor, B. Thomas, T. McDonald, P. Ainsworth, L. Mulligan. (2005).Oncogene.24(6):1091-1097

5) Deep Screening of Recombination Proficient Bacteriophage Libraries., B. Thomas, K. Woltjen, D. Rancourt. (2003)..Biotechniques. 34(1):36-8, 40

6) Screening for acute myocardial injury: creatine kinase is comparable to myoglobin., C. Collier, B. Thomas, E. Dagnone, W. Pickett, M. Raymond. (2000).Clin. Chem. Lab Med. 38:1145-1149

   

fillerperson

Dr. Qian Wang

Position: Postdoctoral Fellow

E-mail: qw1@ualberta.ca

Phone: (780) 492-7437

Supervisor: Dr. Michele Barry

 

 

 

Academic Interests: I'm studying how ectromelin viruses regulate cellular NFkB signaling in virus/host interaction.

Awards:

  • AIHS Post-Doctoral Fellowship

 

G. ZhouDr. Gang Zhou

Position: Postdoctoral Fellow

E-mail: gzhou2@ualberta.ca

Phone: (780) 492-8920

Supervisor: Dr. Kevin Kane

 

 

 

 

Academic Interests: NK cell anti-virus activity; and effective anti-influenza immunotherapies and vaccines

Awards:

  • Postdoctoral Fellowship Award (Manitoba Health Research Council, 2009)
  • Postdoctoral Fellowship Award (Manitoba Institute of Child Health, 2007-2009)
  • Bursary for young immunologists (Federation of Immunology Societies of Asia-Oceania, 2005)

Publications:

1) Zhou G, Ma Y, Jia P, Guan Q, Uzonna JE, Peng Z. Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice. Vaccine. 2010 Feb 17;28(7):1838-46.

2) Ma Y, Guan Q, Bai A, Weiss CR, Hillman CL, Ma A, Zhou G, Qing G, Peng Z. Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis. Inflamm Bowel Dis. 2010 Jun;16(6):1040-50.

3) Guan Q, Ma Y, Hillman CL, Ma A, Zhou G, Qing G, Peng Z. Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis. Vaccine. 2009 Nov 23;27(50):7096-104.

4) Wei L, Zhou G, Li Z, He L, Gao M, Tan J, Lei H. Detection of toxoplasmic lesions in mouse brain by USPIO-enhanced magnetic resonance imaging. Magn Reson Imaging. 2007 Dec; 25(10): 1442-8. Epub 2007 Jul 5.

5) He Li, Zhou Gang, He Yuling, Xie Luokun, Xiong Jie, Lei Hao, Wei Li, Hu Chunsong, Liu Junyan, Jiang Mingshen, Jin Youxin, Gong Feili, Jin Boquan, Tan Jinquan. Different Neurotropic Pathogens Elicit Neurotoxic CCR9- or Neurosupportive CXCR3-Expressing Microglia. J Immunol. 2006 Sep 15;177(6):3644-56.

6) Tan Jinquan, Zhou Gang. Chemokine receptors and transplantation. Cell Mol Immunol. 2005 Oct; 2(5):343-9.

 

Related Links